Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-007938
Filing Date
2025-11-04
Accepted
2025-11-04 08:46:09
Documents
59
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEP 2025 sonoma_i10q-093025.htm   iXBRL 10-Q 717315
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_ex3101.htm EX-31.1 8530
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_ex3102.htm EX-31.2 8448
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 4400
  Complete submission text file 0001683168-25-007938.txt   3969689

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE snoa-20250930.xsd EX-101.SCH 26561
6 XBRL CALCULATION FILE snoa-20250930_cal.xml EX-101.CAL 51798
7 XBRL DEFINITION FILE snoa-20250930_def.xml EX-101.DEF 85283
8 XBRL LABEL FILE snoa-20250930_lab.xml EX-101.LAB 283201
9 XBRL PRESENTATION FILE snoa-20250930_pre.xml EX-101.PRE 229764
62 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_i10q-093025_htm.xml XML 504696
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 251446720
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)